316 related articles for article (PubMed ID: 33743795)
1. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
[TBL] [Abstract][Full Text] [Related]
2. Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.
Debaize L; Jakobczyk H; Avner S; Gaudichon J; Rio AG; Sérandour AA; Dorsheimer L; Chalmel F; Carroll JS; Zörnig M; Rieger MA; Delalande O; Salbert G; Galibert MD; Gandemer V; Troadec MB
Nucleic Acids Res; 2018 Nov; 46(21):11214-11228. PubMed ID: 30500954
[TBL] [Abstract][Full Text] [Related]
3. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
[TBL] [Abstract][Full Text] [Related]
4. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
[TBL] [Abstract][Full Text] [Related]
5. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional corepressor CBFA2T3 inhibits all-
Steinauer N; Guo C; Zhang J
J Biol Chem; 2020 Jul; 295(27):8887-8900. PubMed ID: 32434928
[TBL] [Abstract][Full Text] [Related]
7. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
[TBL] [Abstract][Full Text] [Related]
8. Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
Mehtonen J; Teppo S; Lahnalampi M; Kokko A; Kaukonen R; Oksa L; Bouvy-Liivrand M; Malyukova A; Mäkinen A; Laukkanen S; Mäkinen PI; Rounioja S; Ruusuvuori P; Sangfelt O; Lund R; Lönnberg T; Lohi O; Heinäniemi M
Genome Med; 2020 Nov; 12(1):99. PubMed ID: 33218352
[TBL] [Abstract][Full Text] [Related]
9. Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.
Steinauer N; Guo C; Huang C; Wong M; Tu Y; Freter CE; Zhang J
Blood Adv; 2019 May; 3(9):1379-1393. PubMed ID: 31040112
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL.
Amare Kadam PS; Raje GC; Pais AP; Banavali S
Cancer Genet Cytogenet; 2008 Apr; 182(1):27-32. PubMed ID: 18328947
[TBL] [Abstract][Full Text] [Related]
11. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1.
Tijchon E; van Emst L; Yuniati L; van Ingen Schenau D; Gerritsen M; van der Meer LT; Williams O; Hoogerbrugge PM; Scheijen B; van Leeuwen FN
Exp Hematol; 2018 Apr; 60():57-62.e3. PubMed ID: 29408281
[TBL] [Abstract][Full Text] [Related]
13. RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.
Sharma G; Tran TM; Bansal I; Beg MS; Bhardwaj R; Bassi J; Tan Y; Jaiswal AK; Tso C; Jain A; Singh J; Chattopadhyay P; Singh A; Chopra A; Bakhshi S; Casero D; Rao DS; Palanichamy JK
J Exp Clin Cancer Res; 2023 Sep; 42(1):231. PubMed ID: 37670323
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
15. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.
Piette C; Suciu S; Clappier E; Bertrand Y; Drunat S; Girard S; Yakouben K; Plat G; Dastugue N; Mazingue F; Grardel N; van Roy N; Uyttebroeck A; Costa V; Minckes O; Sirvent N; Simon P; Lutz P; Ferster A; Pluchart C; Poirée M; Freycon C; Dresse MF; Millot F; Chantrain C; van der Werff Ten Bosch J; Norga K; Gilotay C; Rohrlich PS; Benoit Y; Cavé H
Leukemia; 2018 Jan; 32(1):244-248. PubMed ID: 29064485
[No Abstract] [Full Text] [Related]
17. RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells
Liu S; Xing Y; Lu W; Li S; Tian Z; Xing H; Tang K; Xu Y; Rao Q; Wang M; Wang J
Haematologica; 2019 Aug; 104(8):1597-1607. PubMed ID: 30792202
[TBL] [Abstract][Full Text] [Related]
18. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM
Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206
[TBL] [Abstract][Full Text] [Related]
20. Infection Exposure Promotes
Rodríguez-Hernández G; Hauer J; Martín-Lorenzo A; Schäfer D; Bartenhagen C; García-Ramírez I; Auer F; González-Herrero I; Ruiz-Roca L; Gombert M; Okpanyi V; Fischer U; Chen C; Dugas M; Bhatia S; Linka RM; Garcia-Suquia M; Rascón-Trincado MV; Garcia-Sanchez A; Blanco O; García-Cenador MB; García-Criado FJ; Cobaleda C; Alonso-López D; De Las Rivas J; Müschen M; Vicente-Dueñas C; Sánchez-García I; Borkhardt A
Cancer Res; 2017 Aug; 77(16):4365-4377. PubMed ID: 28630052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
